Canadian Food Inspection Agency Canada
Français Contact Us Help Search Canada Site
Home What's New Acts and Regulations Site Map
Food Safety Animal Health Plant Protection Corporate Affairs

bullet Main Page -   Biotechnology
bullet Transparency
- Consultation
- Expert Advice
- Public Access to Information
bullet Food Labelling
bullet International Cooperation
bullet Regulation
bullet Related Sites
bullet Resource Centre
bullet Contact Us

Food > Biotechnology > Labelling 

Communiqué "Labelling of Novel Foods Derived Through Genetic Engineering"

Summary of Comments

Released: December 1, 1995


Please note: The formal consultation for these guideline proposals has closed but your comments are still welcome.

The following document contains proposed guidelines for the labelling of novel foods derived through genetic engineering. Development of the proposed guidelines are the result of a series of consultations with a wide audience of interested participants.

Once finalized, the guidelines will serve as the Government of Canada's policy on the requirements for labelling of novel foods derived through genetic engineering.


The first foods and food ingredients developed through genetic engineering have reached commercialization and more are nearing distribution. In response to these developments, Canada and the other 143 member states of the joint FAO/WHO international food standard setting organization, the Codex Alimentarius Commission, are evaluating questions regarding appropriate labelling requirements for novel foods derived through genetic engineering. An initial series of consultations has been completed in Canada on the labelling of novel foods derived through genetic engineering. Based on the comments received from these fora, a series of points of general consensus and a number of proposed guidelines have been developed. These proposed guidelines, and the rationale underlying their development, are outlined below in the"Discussion Summary, Points of General Consensus and Guideline Proposals" section of this document.

The purpose of this communique is to elicit comment from a wide audience of interested parties on the points of consensus and proposed guidelines respecting consumer information that have been developed and applied to date on an interim basis with respect to the labelling of novel foods derived through genetic engineering.

The results of this consultative process will form the basis of the Canadian position for the upcoming Codex Alimentarius Food Labelling Committee meeting to be held in Ottawa in May 1996. In addition, it is anticipated that comments received on the points of consensus will support the application of the proposed guidelines, or serve as the basis for their appropriate modification.

Novel foods are:

  1. Foods that have not previously been used as food,
  2. foods from a process not previously used for food in Canada, or
  3. foods modified such that:
    1. the food results from genetic manipulation and exhibits one or more characteristics that were not previously identified in that food, or the food results from production by a genetically manipulated organism exhibiting such new characteristics,
    2. the food contains microorganisms not previously used as a food or to process food, or
    3. the food is modified from the traditional product or produced by a process that has been modified from the traditional process (Novel Food Guidelines, September 1994).

Genetic engineering is:

The transfer of characteristics, through specific genetic information, from one organism to another. Genetic engineering is a relatively new technique of biotechnology -- the umbrella term describing a broad spectrum of applications used to produce new products. A combination of genetic engineering with traditional methods allows for the development of plants, animals and foods with novel characteristics.

Labels on food products in Canada serve three main functions:

  1. To ensure adequate and accurate information relative to health, safety and economic concerns and to assist consumers in making food choices;
  2. To protect consumers and industry from fraudulent or deceptive labelling, packaging, and advertising practices; and,
  3. To promote fair competition and product marketability.

The responsibility for the establishment of non-safety food labelling policy in Canada lies with Agriculture and Agri-Food Canada (AAFC). For specific labelling requirements based on health or safety considerations, Health Canada assumes the principal responsibility for policy setting, while AAFC or Fisheries and Oceans administers this policy.

Food labelling in Canada is regulated primarily under the authority of the Food and Drugs Act. Regulations under this Act require that labels contain, among other things, the following basic information: common name, list of ingredients, name and address of manufacturer or other responsible party, durable life information on products with a shelf life of up to 90 days, and various other product specific information (such as % milk fat in certain dairy products), and specific information in support of nutrition claims. In addition to the basic information, there are comprehensive guidelines controlling nutrition and marketing claims.

Regulations under the Consumer Packaging and Labelling Act require net quantity designations.There are also specialized labelling requirements under the Canada Agricultural Products Act,the Meat Inspection Act and the Fish Inspection Act dealing with grade statements, country of origin and other specific commodity information. Advertisements for food and beverages are subject to the requirements of the Food and Drugs Act and the Consumer Packaging and Labelling Act .

Prior to drafting this communique, several public consultations were conducted.

November 1993 -- At the Workshop on Regulating Agricultural Products of Biotechnology held in Ottawa November 8-10, 1993, a range of views was expressed regarding the labelling of genetically engineered foods. Consensus was reached among participants regarding the need for appropriate labelling for health and safety issues. It was apparent that further consultation among all interested parties would be necessary, however, in order to provide a clear outline of other fundamental principles that needed to be considered when developing policy, guidelines or regulations for the labelling of novel foods derived through genetic engineering.
October 1994 -- The Codex Alimentarius Committee on Food Labelling (CCFL) is the forum that sets international food labelling standards and guidelines aimed at protecting the health of consumers,ensuring fair practices in food trade, and promoting harmonization of food standards and labelling requirements. The standards established by the Codex Alimentarius Commission have been accepted as the basis for the Sanitary and Phytosanitary agreement of the World Trade Organization.

At the Codex Food Labelling Committee meeting on October 24-28, 1994, member countries discussed the issue of the labelling of genetically engineered foods. During these initial discussions, views were generally split among countries favouring mandatory food labelling only for instances involving the introduction of any potential health and/or safety concerns to food products, and those countries advocating that labelling be required under all circumstances. All countries were asked to develop a more definitive national position for discussion at the next Labelling Committee meeting in Ottawa in May 1996.

During their July 1995 meeting, the 21st session of the Codex Alimentarius Commission approved the principle that Codex Alimentarius food standards shall be based on sound scientific analysis to assure the quality and safety of the food supply.

November 1994 -- The departments responsible for the labelling of food in Canada - Agriculture and Agri-Food Canada, Industry Canada, Health Canada, and the Department of Fisheries and Oceans convened a Technical Workshop on the Labelling of Novel Foods Derived Through Genetic Engineering in Ottawa on November 24-25, 1994. This workshop served as a first step in the process of developing a Canadian labelling policy for novel foods derived through genetic engineering. Participants represented a wide range of stakeholders including universities, nutritionists, dietitians, manufacturers, distributors, processors, producers, consumer groups, advertisers, commodity organizations, organic growers, environmental and food non-governmental organizations, provincial governments and the federal government.

November 1994 workshop participants were asked to consider a number of questions and points of fact. General consensus was reached on a number of issues. Subsequently, these points of general consensus served as the basis for the development of the proposed labelling guidelines. The background discussion, points of general consensus and resulting guideline proposals are as follows:

  1. Should Novel Foods Derived Through Genetic Engineering be Labelled?

    Health Canada is currently developing regulations which will require notification prior to the sale, or advertising for sale, of novel foods, including those developed using genetic engineering. Guidance regarding the notification and information necessary to conduct a safety assessment of foods derived from genetically modified plants and microorganisms is provided in the document,"Guidelines for the Safety Assessment of Novel Foods, Volume I and II". Safety evaluations of genetically engineered products may include an assessment of: the composition of the novel product and comparison to the composition of its traditionally derived counterpart; the impact of the inserted genetic material (novel trait) on the nutrient content of the food; and the toxicological properties of the food as necessary. In addition, the issue of allergenicity would be addressed where potential allergens are present in the food.

    Workshop participants unanimously agreed that where there is an identified health and/or safety risk for certain individuals or population segments related to a novel food derived through genetic engineering, e.g. the introduction of an allergen, consumers need this information, and it should be provided through labelling.

    The allergens of concern are those causing severe adverse reactions. As part of the regulatory review of the Food and Drug Regulations currently underway, a priority list of foods causing adverse reactions, e.g., allergens, is being developed by Health Canada and Agriculture and Agri-Food Canada with the aim of requiring their label disclosure under all circumstances.

    Participants also agreed that if a foods composition was altered significantly, e.g. through a significant nutrient change, this information should be indicated on the product label. Nutrient changes could also be grounds for non-acceptance of a product if, for example, a significant reduction in nutritional quality has occurred. Alternately, consideration could be given to assigning a new common name for the product, if changes were major. New names have been assigned to foods with modified composition in the past. As an example, rapeseed was renamed 'canola' when certain varieties were transformed through the use of traditional plant breeding techniques into edible food product(s).

    General Consensus:

    The labelling of novel foods derived through genetic engineering should be required to identify:

    1. potential health and/or safety risks for certain individuals or population segments and
    2. significant compositional or nutritional changes from the traditional food source(s).
    Guideline Proposal #1:

    Labels of novel foods or novel food ingredients derived through genetic engineering must identify the presence of:

    • potential health and/or safety risks for individuals or population segments (e.g. the introduction of food allergens); and/or,
    • significant compositional or nutritional changes from the traditional food source which have occurred in the product (eg. a change in the fatty acid profile of vegetable oil).
  2. The Consumers' Right To Know

    There was unanimous agreement among workshop participants that consumers have a right to information in order to make informed choices about the purchase of food products. Government and industry were seen to have an obligation to provide information that would assist consumers to make these choices.

    Some participants asserted that only full disclosure on a label of all components of a product would satisfy the right to know. Others were concerned that it may not be possible for Health Canada to determine all long-term risks during pre-market assessments and that the labelling of all foods subjected to genetic engineering would therefore be necessary for those who wished to avoid such foods.

    However, while participants agreed that consumers should have access to this information and that manufacturers have an obligation to provide it, it was also recognized that providing it on the label could be highly impractical, and that the label itself should be generally reserved for identifying health and safety concerns. The label was seen as only one option for making information available to consumers related to the production techniques used in the development of the food and not necessarily the most appropriate vehicle in all cases. It was considered that alternative methods should be examined. Workshop participants identified a number of additional means of providing information of this nature to the consumer, including:

    1. Point of sale information
    2. Centralized databanks of information
    3. Internet
    4. 1-800 telephone numbers on the label
    5. Advertising
    6. Public service announcements
    7. Mass media

    For those wishing to avoid novel foods derived through genetic engineering, access to organic foods was suggested as an alternative option. Organic methods of production do not permit the use of genetically engineered products. Production standards for organic foods are currently being placed in federal regulations under the Canada Agricultural Products Act. Workshop participants felt it might also be possible for individuals or organizations to establish additional mechanisms, such as certification boards, to ensure that only traditionally derived food sources were used in certain foods and food products.

    A general consensus emerged that a blanket statement on the label of all novel foods derived through genetic engineering to indicate that they have been developed utilizing the process of genetic engineering, was unnecessary. Participants believed that if the food had undergone a safety review by Health Canada and been determined to be safe, and no specific labelling was required to identify the presence of potential allergens or to indicate that significant compositional changes had occurred, blanket labelling should not be required.

    A concern with blanket labelling was that such requirements, especially if required to appear on products that are used to produce a wide range of other foods (eg. tomatoes used to make tomato paste, soups, sauces, ketchup, pizza, etc.) could eventually result in the great majority of all food product labels bearing a statement regarding genetic engineering. This situation could potentially cause important health or safety information to be overlooked by those individuals who require it, e.g., persons with severe food allergies or hypersensitivities. An added consideration was the increased costs that companies and ultimately consumers would likely face in the form of higher product prices, if a blanket labelling policy were adopted.

    General Consensus:

    While acknowledging the right of consumers to information regarding the composition of the foods they purchase, a blanket labelling policy to specifically identify novel foods derived through genetic engineering would not provide the consumer any additional information regarding the safety of the food.

    Guideline Proposal #2:

    Unless potential health and/or safety, or significant nutritional or compositional changes have occurred, (as per proposal #1) the fact that the process of genetic engineering has been utilized need not be identified on food labels.

  3. What Should Appear on a Label?

    Participants at the November 1994 workshop agreed that labels should:

    1. be kept as simple as possible,
    2. be relevant and understandable, and
    3. be truthful and not misleading.

    Workshop participants also believed that for those companies that wished to label their food products as 'derived through genetic engineering' (voluntary positive labelling) or 'not derived through genetic engineering' (voluntary negative labelling), it was important that clear criteria be developed to ensure consistency. Once the criteria are in place, labels should be reviewed as required by the responsible department, to determine their appropriateness.

    From a regulatory stand point, negative labelling of non-genetically engineered foods, e.g., 'this product was not produced using genetic engineering', can be used in accordance with current policy, provided the statement is truthful and not misleading. Such labelling, however, was seen by many to convey an unnecessarily negative image about comparable foods which have been derived through genetic engineering. Some participants suggested that an alternative, more positive statement, indicating that the food was produced using conventional technologies, would be a more appropriate approach.

    As indicated earlier, participants believed that labels should be reserved for providing critical information on identified health and safety risks for certain individuals or population segments, e.g., allergens. In addition, there was general consensus that if there was significant compositional alterations to the food, e.g., altered fatty acid composition of vegetable oil, this fact should require declaration on the label. A major compositional change to the product may also require a new common name.

    General Consensus:

    Food labels should be understandable, truthful and not misleading. Voluntary labelling is acceptable but it must be truthful. Criteria for labels to ensure consistency should be developed and put in place. The required labelling information should address any health/safety, nutritional or compositional change to the food that may be of concern to consumers, rather than focussing on the process used to obtain the change.

    Guideline Proposal #3:
    1. The labelling of novel foods or food ingredients derived through genetic engineering should be understandable, truthful and not misleading;
    2. Voluntary positive labelling that is intended to indicate that a novel food or novel food ingredient has been produced by, or has particular attributes resulting from, genetic engineering is acceptable, on condition that the claim is not misleading or deceptive and the claim itself is factual. Responsible parties should be in a position to support the claim(s) being made. (Violations would be subject to the enforcement measures and penalties provided under the Food and Drugs Act).
    3. Voluntary negative labelling that is intended to indicate that a novel food or novel food ingredient has been produced without the use of genetic engineering, is acceptable, on condition that the claim is not misleading or deceptive and the claim itself is factual. Responsible parties should be in a position to support the claim(s) being made. (Violations would be subject to the enforcement measures and penalties provided under the Food and Drugs Act).
  4. How Should Dietary Restrictions Based on Religious Requirements Be Addressed?

    The general view of the participants was that the role of government is to address health, safety and fraud issues, and that dietary preferences based on religious grounds should be accommodated through existing control mechanisms established by the religious groups concerned, e.g., food production, handling and processing systems based on the requirements of Jewish (Kosher) or Islamic (Halal) law.

    General Consensus:

    Dietary restrictions based on religious requirements could adequately be addressed within the existing regulatory framework of religious groups with no additional procedures required.

    Guideline Proposal #4:

    Dietary restrictions based on religious requirements is outside the current mandate of government and is being adequately addressed within the present regulatory framework of religious groups. A guideline provision is not therefore required.

  5. How should Canada proceed with respect to its international trading partners?

    In view of Canada's international trade commitments, it was felt that Canada's ultimate approach to the labelling of novel foods derived through genetic engineering should be harmonized, where possible, with international standards.

    General Consensus:

    In the development of its labelling policy, in addition to considering domestic labelling needs, Canada should also consider the need for consistency, where possible, with the principles of its major trading partners and international standards.

    Guideline Proposal #5:

    Canada must consider both domestic and international needs in food labelling matters.

    The proposed guidelines outlined above have been used in Canada on an interim basis to determine what, if any, labelling requirements should be applied to those novel foods derived through genetic engineering which have been approved for sale in Canada.

    For example, microbial enzymes are used in cheese production. Previously, all of the commercial rennin, a milk clotting enzyme used to make cheese, came from rennet taken from the lining of slaughtered calves' stomachs.

    Recently, a rennin (chymosin) derived from genetically modified microorganisms has been introduced into the marketplace. Chymosin is produced through a fermentation process that does not require calves' stomachs, and offers a more consistent, reliable supply. Chymosin is utilized in numerous processed dairy products, e.g., cheese, in the same manner as calves' rennet. Health Canada conducted a thorough safety evaluation of this enzyme. No specific labelling was determined to be required to indicate that the chymosin was derived through genetic engineering, based on health, safety or compositional changes.

    Health Canada has recently concluded its safety evaluation of a new tomato variety genetically engineered in a manner that delays softening upon ripening. No special labelling will be required based on health, safety or composition reasons. Health Canada had no objection to factual statements made in promotional materials accompanying the tomato at point of sale which explained that the novel trait was achieved through genetic engineering.

    Several genetically engineered canola varieties have recently undergone food and environmental safety reviews. The modifications were agronomic traits and conferred no change to the edible portion (vegetable oil) of the plant and thus no special labelling was required.

    New canola and other edible oilseed crops are on the horizon wherein there will be changes to the composition of the edible oil, e.g., oil modified to reduce the saturated fat content. Because a significant compositional change is involved these modifications would be made known to the consumer on the product label.- - - - -

    This bulletin is published by the Food Inspection Directorate. For further information, please contact:

    Associate Director
    Biotechnology Strategies and Coordination Office
    Food Inspection Directorate
    Food Production & Inspection Branch
    Agriculture and Agri-Food Canada
    59 Camelot Drive
    Nepean, Ontario, K1A 0Y9
    Telephone: (613) 952-8000
    Facsimile: (613) 941-9421



Top of Page
Top of Page
Important Notices